Understanding Supply Sustainability of Plasma-derived Medicinal Products Drivers and Consequences of Shortages

The authors describe the results of a literature review on the societal and economic effects of plasma-derived medicinal products (PDMPs) including intravenous immunoglobulins (IVIgs). They identify issues that may constrain the supply of these products and suggest policy interventions to ensure sustainable use and exploring the use of alternative treatments to mitigate shortage risks and maintain access to life-saving treatments.